会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Color cathode-ray tube and method of manufacturing the same
    • 彩色阴极射线管及其制造方法
    • US5801479A
    • 1998-09-01
    • US681333
    • 1996-07-23
    • Masaki Shinoda
    • Masaki Shinoda
    • H01J29/07H01J29/06
    • H01J29/07H01J2229/0761
    • A cathode-ray tube consuppress deterioration and reduce unevenness in color of a picture by preventing an electrode element thereof from being twisted. The color cathode-ray tube includes a frame and an aperture grill stretched across and fixed on the frame and having an electrode element. The aperture grill is stretched across and fixed on the frame in a state that the frame is applied with a compressive force and the aperture grill is applied with a tension. In a process of stretching and fixing the aperture grill across and on the frame, of the tension applied to the aperture grill, a maximum tension applied to the electrode element is set within the range from 30% to 85% of a tensile strength of the electrode element.
    • 阴极射线管通过防止其电极元件扭曲而抑制图像的劣化并减少图像的颜色不均匀。 彩色阴极射线管包括一个框架和一个横跨并固定在框架上并具有电极元件的孔格栅。 孔格栅在被施加压缩力并且孔格栅施加张力的状态下被拉伸并固定在框架上。 在将孔格栅拉伸并固定在框架上并在框架上施加到孔格栅上的张力的过程中,施加到电极元件的最大张力设定在拉伸强度的30%至85%的范围内 电极元件。
    • 9. 发明授权
    • Color selection mechanism and color cathode-ray tube
    • 颜色选择机构和彩色阴极射线管
    • US06433468B1
    • 2002-08-13
    • US09596042
    • 2000-06-16
    • Masaki Shinoda
    • Masaki Shinoda
    • H01J2907
    • H01J29/07H01J2229/0761
    • Disclosed is a color-selection mechanism with an aperture-grill type, color-selection electrode which includes tapes and slits that are disposed between the tapes. In this mechanism, when the arranged pitch of the slits is in the range of 0.310 to 0.221 mm, the width of the flat portion on the panel side of each tape of the color selection electrode is set to be 0.215 to 0.050 times the slit pitch, which is narrower than that in the related art, and when the arranged pitch of the slits is in the range of 0.220 to 0.100 mm, the width of the flat portion on the panel side of each tape of the color selection electrode is set to be 0.225 to 0.050 times the slit pitch, which is narrower than that in the related art. With this configuration, the amount of reflection of an electron beam that has been reflected from the inner surface of the panel from the flat portion on the panel side of each tape to an undesired phosphor can be reduced. As a result, the degradation of color purity in a CRT can be reduced.
    • 公开了一种具有孔格栅型的选色机构,选色电极包括布置在带之间的带和狭缝。 在该机构中,当狭缝的排列间距在0.310〜0.221mm的范围内时,选色电极的各条带的面板侧的平坦部的宽度被设定为狭缝间距的0.215〜0.050倍 ,其狭缝的间距在0.220〜0.100mm的范围内,选色电极的每个带的面板侧的平坦部的宽度被设定为 为狭缝间距的0.225〜0.050倍,比现有技术中窄。 利用这种结构,可以减少从面板内表面反射的电子束从各带的面板侧的平坦部分到不需要的荧光体的反射量。 结果,可以降低CRT中色纯度的降低。
    • 10. 发明授权
    • Pharmaceuticals containing prostaglandin I.sub.2
    • 含有前列腺素I2的药物
    • US5053526A
    • 1991-10-01
    • US511945
    • 1990-04-16
    • Masakatsu ShibasakiMikiko SodeokaYuji OgawaToshiaki MaseAkira IshibashiDaijiro HoriiToshiji KanayamaKatsuhiko IsekiMasaki ShinodaChiyoko IshiyamaYoshio Hayashi
    • Masakatsu ShibasakiMikiko SodeokaYuji OgawaToshiaki MaseAkira IshibashiDaijiro HoriiToshiji KanayamaKatsuhiko IsekiMasaki ShinodaChiyoko IshiyamaYoshio Hayashi
    • A61K31/557C07C405/00
    • C07C405/0083A61K31/557
    • Disclosed is a pharmaceutical having circulation ameliorating effect and antiulcer effect containing a prostaglandin I.sub.2 analogue represented by the formula shown below or a non-toxic salt of its salt or a cyclodextrin inclusion compound thereof as the effective ingredient: ##STR1## wherein R.sup.1 represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a cycloalkyl group having 4 to 7 carbon atoms or a phenyl group; A represents a pentyl group, a cyclopentyl group, a cyclohexyl group, a 1-methyl-3-hexynyl group, a 2-methyl-3-hexynyl group, a 1-methylhexyl group, a 2-phenethyl group, a 1,1-dimethylpentyl group, a 2-methylpentyl group, a 1-cyclohexylethyl group, a 2-methylhexyl group, a 1-methyl-3-pentynyl group or 1 2,6-dimethyl-5-heptenyl group; the double bond between the carbon atoms at 4- and 5-positions is E or Z or a mixture thereof, the asymmetric center in the substituent represented by A is R-configuration or S-configuration or a mixture thereof.The pharmaceuticals containing, as an active ingredient, prostaglandin I.sub.2 analogues of the present invention have potent platelet aggregation inhibiting effect, blood pressure depressing effect, vasodilative effect and antiulcer effect, and are also low in toxicity.
    • 本发明公开了一种具有循环改善作用和抗溃疡效果的药物,其含有下述式表示的前列腺素I2类似物或其盐的无毒性盐或其环糊精包合物作为有效成分:其中R1表示氢 原子,碳原子数1〜12的烷基,碳原子数4〜7的环烷基或苯基; A表示戊基,环戊基,环己基,1-甲基-3-己炔基,2-甲基-3-己炔基,1-甲基己基,2-苯乙基,1,1 2-甲基戊基,2-甲基戊基,1-环己基乙基,2-甲基己基,1-甲基-3-戊炔基或1,6-二甲基-5-庚烯基; 在4-和5-位碳原子之间的双键是E或Z或其混合物,由A表示的取代基中的不对称中心是R-构型或S-构型或其混合物。 含有本发明的前列腺素I2类似物作为活性成分的药物具有有效的血小板聚集抑制作用,降血压作用,血管扩张作用和抗溃疡作用,毒性也低。